An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery

Pharmacotherapy

Volumn 22, Issue 1, 2002, Pages 75-80

  Reddy, Prabashni ^a   Dunn, Alisha B ^b   White, C Michael ^a   Tsikouris, James P ^c   Giri, Satyendra ^d   Kluger, Jeffrey ^d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

^d HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; AGED; ANAMNESIS; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG TOLERANCE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL COST; HOSPITAL DEPARTMENT; HOSPITAL PHARMACY; HUMAN; INCIDENCE; INJECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; OPERATING ROOM; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SENESCENCE; WARD;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG COSTS; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; PREMEDICATION;

EID: 0036137624     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.1.75.33498     Document Type: Article

References (26)

1. Atrial fibrillation following coronary, artery bypass surgery: Predictors, outcomes and resource utilization
2. Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources
3. Atrial fibrillation after bypass surgery: Does the arrhythmia or the characteristics of the patients prolong hospital stay?
4. Hazards of postoperative atrial arrhythmias
5. Prevention of postoperative atrial fibrillation: What is the best approach?
6. Atrial fibrillation following coronary artery bypass surgery
7. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery
8. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: A meta-analysis of randomized control trials
9. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting
10. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association task force on practice guidelines
11. Oral d, l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study
12. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
13. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): A randomized, placebo-controlled trial
14. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
15. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations
16. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The amiodarone reduction in coronary heart (ARCH) trial
17. Does prophylaxis against atrial fibrillation after cardiac surgery reduce length of stay or hospital costs?
18. An economic comparison of amiodarone versus placebo in the prevention of atrial fibrillation after open heart surgery
19. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery
20. Estimating costs in cost-effectiveness analysis
21. Problems in undertaking pharmacoeconomic assessments in phase III clinical trials: The case of colony-stimulating factors
22. Methods for comparison of cost data
23. Dealing with skewed data: An example using asthma-related costs of Medicaid clients
24. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty
25. Costing medical care: Using medicare administrative data
26. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification?